Plain-English translation of NCT04119544 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Stroke research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
After a stroke, many people lose the ability to use their affected arm. This trial is testing whether a device called the IVS3 (Intensive Visual Simulation device) — which uses a large screen to create the illusion that your weak arm is moving normally — can help you regain better control and movement in your hand and wrist when combined with standard therapy.
Most stroke patients don't regain full use of their affected arm because they stop trying to use it. This trial wants to see if the new treatment makes standard rehabilitation more effective by using an immersive visual trick to encourage your brain and arm to work together.
You likely qualify if…
You likely don't qualify if…
You will attend rehabilitation sessions at least 4 times per week for 6 weeks. Each session lasts about 1 hour. Depending on which group you're assigned to, you'll either receive standard occupational therapy alone, or standard therapy combined with 15 minutes using the mirror therapy device. The device uses a large adjustable screen to show your arm moving normally, creating a visual illusion. Your participation will continue for 18 weeks total, with follow-up visits to measure how much your arm function has improved.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
France